序号 |
标题 |
次数 |
作者 |
发布时间 |
76906 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP(CAS: 2055042-82-3) |
120 |
WYQ |
2024-12-19 |
76907 |
Mal-amido-PEG8-val-gly-PAB-OH(CAS: 2353409-52-4) |
118 |
WYQ |
2024-12-19 |
76908 |
cas:160854-54-6,4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene,ADC定制 |
105 |
wyh |
2024-12-19 |
76909 |
cas:2504147-59-3 MC (C5)-Val-Cit |
144 |
zyl |
2024-12-19 |
76910 |
Boc-PEG4-Val-Ala-PAB,可降解的ADC连接体 |
153 |
WYQ |
2024-12-19 |
76911 |
cas:2058075-34-4,DGN549-C , ADC试剂 |
132 |
kx |
2024-12-19 |
76912 |
CAS: 1639939-40-4,Mal-Val-Ala-PAB-PNP,马来酰亚胺-VAL-ALA-PAB-PNP |
144 |
WYQ |
2024-12-19 |
76913 |
Fmoc-VC-PAB-Duocarmycin SA, ADC试剂 |
110 |
kx |
2024-12-19 |
76914 |
Mal-PEG4-Val-Ala-PAB,可降解的ADC(抗体偶联药物)连接子 |
181 |
WYQ |
2024-12-19 |
76915 |
Mal-PEG1-Val-Cit-OH的介绍 |
145 |
zyl |
2024-12-19 |
76916 |
MC-vc-PAB-Monomethyl dolastatin10, ADC试剂 |
98 |
kx |
2024-12-19 |
76917 |
CAS: 1870916-87-2,Mal-Val-Ala-PAB,马来酰亚胺-缬氨酸-丙氨酸-对氨基苯甲酸 |
114 |
WYQ |
2024-12-19 |
76918 |
cas:2395887-69-9 Mal-PEG2-Val-Cit-PAB-PNP |
97 |
zyl |
2024-12-19 |
76919 |
SuO-Val-Cit-PAB-MMAE, ADC试剂 |
92 |
kx |
2024-12-19 |
76920 |
Mal-PEG4-Val-Ala-PAB-PNP的介绍 |
98 |
zyl |
2024-12-19 |
76921 |
CAS: 2348405-93-4,DBCO-PEG4-Val-Ala-PAB-PNP |
86 |
WYQ |
2024-12-19 |
76922 |
CAS: 2348405-92-3,DBCO-PEG4-Val-Ala-PAB |
100 |
WYQ |
2024-12-19 |
76923 |
cas:2112738-13-1 Mal-amido-PEG2-Val-Cit-PAB-PNP |
99 |
zyl |
2024-12-19 |
76924 |
Azido-PEG4-Val-Ala-PAB,分子式:C29H48N8O9 |
90 |
WYQ |
2024-12-19 |
76925 |
cas:2055896-86-9,MC-Val-Cit-PAB-tubulysin5a , ADC试剂 |
100 |
kx |
2024-12-19 |
76926 |
Azido-PEG8-Val-Cit-PAB-PNP |
92 |
zyl |
2024-12-19 |
76927 |
cas:2055896-83-6,MC-Val-Cit-PAB-carfilzomib , ADC试剂 |
118 |
kx |
2024-12-19 |
76928 |
MAL-di-EG-Val-Cit-PAB-MMAF, ADC试剂 |
94 |
kx |
2024-12-19 |
76929 |
cas:2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
113 |
zyl |
2024-12-19 |
76930 |
Hydrazone-doxorubicin, ADC试剂 |
188 |
kx |
2024-12-19 |
76931 |
DBCO-C4-Val-Cit-PABC-PNP |
99 |
zyl |
2024-12-19 |
76932 |
cas:644981-35-1 Val-Cit-PAB-MMAE |
100 |
zyl |
2024-12-19 |
76933 |
cas:170908-81-3,DOTA-NHS ester ,1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
88 |
kx |
2024-12-19 |
76934 |
endo-BCN-PEG4-Val-Cit-PAB-MMAE的介绍 |
90 |
zyl |
2024-12-19 |
76935 |
cas:2259318-50-6,MA-PEG4-VA-PBD , ADC试剂 |
107 |
kx |
2024-12-19 |
76936 |
CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 |
77 |
WYQ |
2024-12-19 |
76937 |
CAS: 2768446-73-5,DBCO-Val-Cit-PAB-MMAE |
93 |
WYQ |
2024-12-19 |
76938 |
MC-vc-PAB-C6-a-amanitin, ADC试剂 |
80 |
kx |
2024-12-19 |
76939 |
cas:663598-98-9,2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate,ADC定制 |
100 |
wyh |
2024-12-19 |
76940 |
cas:2873452-49-2 MC-EVCit-PAB-MMAE |
96 |
zyl |
2024-12-19 |
76941 |
2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate,ADC定制 |
114 |
wyh |
2024-12-19 |
76942 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin |
126 |
zyl |
2024-12-19 |
76943 |
Gly3-vc-PAB-MMAE, ADC试剂 |
114 |
kx |
2024-12-19 |
76944 |
CAS: 1869126-64-6, Azido-PEG4-Val-Cit-PAB-MMAE |
101 |
WYQ |
2024-12-19 |
76945 |
cas:2353409-54-6 , Mal-amido-PEG8-Val-Gly,ADC定制 |
115 |
wyh |
2024-12-19 |
76946 |
Azido-PEG4-Val-Ala-PAB-PNP |
116 |
zyl |
2024-12-19 |
76947 |
NOTA-(NGR)2 NOTA偶联NGR二聚体 |
91 |
h |
2024-12-19 |
76948 |
1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid,ADC定制 |
97 |
wyh |
2024-12-19 |
76949 |
CAS: 1343476-44-7,Val-Ala-PAB-OH |
91 |
WYQ |
2024-12-19 |
76950 |
MC-PBD, ADC试剂 |
103 |
kx |
2024-12-19 |